{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:07:21Z","timestamp":1790654841626,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T00:00:00Z","timestamp":1651968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T00:00:00Z","timestamp":1651968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004916","name":"funda\u00e7\u00e3o de amparo \u00e0 pesquisa do estado do amazonas","doi-asserted-by":"publisher","award":["1094\/2013"],"award-info":[{"award-number":["1094\/2013"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"conselho nacional de desenvolvimento cient\u00edfico e tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Over a third of the world\u2019s population is at risk of <jats:italic>Plasmodium vivax<\/jats:italic>-induced malaria. The unique aspect of the parasite\u2019s biology and interactions with the human host make it harder to control and eliminate the disease. Glucose-6-phosphate dehydrogenase (G6PD) deficiency and Duffy-negative blood groups are two red blood cell (RBC) variations that can confer protection against malaria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Molecular genotyping of G6PD and Duffy variants was performed in 225 unrelated patients (97 with uncomplicated and 128 with severe vivax malaria) recruited at a Reference Centre for Infectious Diseases in Manaus. G6PD and Duffy variants characterizations were performed using Real Time PCR (qPCR) and PCR\u2013RFLP, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The Duffy blood group system showed a phenotypic distribution Fy(a\u2009+\u2009b\u2212) of 70 (31.1%), Fy(a\u2009+\u2009b\u2009+) 96 (42.7%), Fy(a\u2212b\u2009+) 56 (24.9%) and Fy(a\u2212b\u2212) 1 (0.44%.) The genotype <jats:italic>FY*A\/FY*B<\/jats:italic> was predominant in both uncomplicated (45.3%) and severe malaria (39.2%). Only one Duffy phenotype Fy(a-b) was found and this involved uncomplicated vivax malaria. The G6PD c.202G\u2009&gt;\u2009A variant was found in 11 (4.88%) females and 18 (8.0%) males, while c.376A\u2009&gt;\u2009G was found in 20 females (8.88%) and 23 (10.22%) male patients. When combined GATA mutated and c.202G\u2009&gt;\u2009A and c.376A\u2009&gt;\u2009G mutated, was observed at a lower frequency in uncomplicated (3.7%) in comparison to severe malaria (37.9%). The phenotype Fy(a\u2212b\u2009+) (p\u2009=\u20090.022) with <jats:italic>FY*B\/FY*B<\/jats:italic> (p\u2009=\u20090.015) genotype correlated with higher parasitaemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A high prevalence of G6PD c202G\u2009&gt;\u2009A and c.376A\u2009&gt;\u2009G and Duffy variants is observed in Manaus, an endemic area for vivax malaria. In addition, this study reports for the first time the Duffy null phenotype Fy(a-b-) in the population of the Amazonas state. Moreover, it is understood that the relationship between G6PD and Duffy variants can modify clinical symptoms in malaria caused by <jats:italic>P<\/jats:italic>. <jats:italic>vivax<\/jats:italic> and this deserves to be further investigated and explored among this population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-022-04165-y","type":"journal-article","created":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T05:02:58Z","timestamp":1651986178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Duffy blood system and G6PD genetic variants in vivax malaria patients from Manaus, Amazonas, Brazil"],"prefix":"10.1186","volume":"21","author":[{"given":"Nat\u00e1lia S.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Lorena S.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio Roberto L.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Cristine G.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda C.","family":"Anselmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius G.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendranath","family":"Ramasawmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilda S.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 P.","family":"Moura Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,8]]},"reference":[{"key":"4165_CR1","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1172\/JCI33996","volume":"118","author":"BM Greenwood","year":"2008","unstructured":"Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, Duffy PE. Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008;118:1266\u201376.","journal-title":"J Clin Invest"},{"key":"4165_CR2","unstructured":"WHO. World Malaria Report. Geneva, World Health Organization, 2015."},{"key":"4165_CR3","unstructured":"Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. (Internet) www.saude.gov.br\/svs Vers\u00e3o 1, 23 de abril de 2021."},{"key":"4165_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1179\/102453312X13221316477336","volume":"17","author":"KS Akinosoglou","year":"2012","unstructured":"Akinosoglou KS, Solomou EE, Gogos CA. Malaria: a haematological disease. Hematology. 2012;17:106\u201314.","journal-title":"Hematology"},{"key":"4165_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4269\/ajtmh.2009.80.194","volume":"80","author":"DK Kochar","year":"2009","unstructured":"Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009;80:194\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"4165_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1475-2875-9-115","volume":"9","author":"J Oliveira-Ferreira","year":"2010","unstructured":"Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT. Malaria in Brazil: an overview. Malar J. 2010;9:115.","journal-title":"Malar J"},{"key":"4165_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1475-2875-11-12","volume":"11","author":"MV Lacerda","year":"2012","unstructured":"Lacerda MV, Mour\u00e3o MP, Alexandre MA, Siqueira AM, Magalh\u00e3es BM, Martinez-Espinosa FE, et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J. 2012;11:12.","journal-title":"Malar J"},{"key":"4165_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/CMR.00074-12","volume":"26","author":"JK Baird","year":"2013","unstructured":"Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26:36\u201357.","journal-title":"Clin Microbiol Rev"},{"key":"4165_CR9","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3201\/eid1610.100685","volume":"16","author":"MA Alexandre","year":"2010","unstructured":"Alexandre MA, Ferreira CO, Siqueira AM, Magalh\u00e3es BL, Mour\u00e3o MP, Lacerda MV, et al. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis. 2010;16:1611\u20134.","journal-title":"Emerg Infect Dis"},{"key":"4165_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1590\/S0074-02762011000900012","volume":"106","author":"JP Quintero","year":"2011","unstructured":"Quintero JP, Siqueira AM, Tob\u00f3n A, Blair S, Moreno A, Ar\u00e9valo-Herrera M, et al. Malaria-related anaemia: a Latin American perspective. Mem Inst Oswaldo Cruz. 2011;106:91\u2013104.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4165_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1475-2875-11-135","volume":"11","author":"NM Douglas","year":"2012","unstructured":"Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, et al. The anaemia of Plasmodium vivax malaria. Malar J. 2012;11:135.","journal-title":"Malar J"},{"issue":"202","key":"4165_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1086\/654815","volume":"15","author":"BO Carvalho","year":"2010","unstructured":"Carvalho BO, Lopes SC, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis. 2010;15(202):638\u201347.","journal-title":"J Infect Dis"},{"key":"4165_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1086\/653211","volume":"202","author":"TW Yeo","year":"2010","unstructured":"Yeo TW, Lampah DA, Tjitra E, Piera K, Gitawati R, Kenangalem E, et al. Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua. Indonesia J Infect Dis. 2010;202:109\u201312.","journal-title":"Indonesia J Infect Dis"},{"key":"4165_CR14","doi-asserted-by":"crossref","unstructured":"Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295:302\u20134.","DOI":"10.1056\/NEJM197608052950602"},{"key":"4165_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ng0695-224","volume":"10","author":"C Tournamille","year":"1995","unstructured":"Tournamille C, Colin Y, Cartron JP, Le Van KC. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet. 1995;10:224\u20138.","journal-title":"Nat Genet"},{"key":"4165_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-3148.2011.01129.x","volume":"22","author":"BR Cruz","year":"2012","unstructured":"Cruz BR, Chiba AK, Moritz E, Bordin JO. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med. 2012;22:84\u20139.","journal-title":"Transfus Med"},{"key":"4165_CR17","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00436-010-1745-x","volume":"106","author":"SR Albuquerque","year":"2010","unstructured":"Albuquerque SR, Cavalcante Fde O, Sanguino EC, Tezza L, Chacon F, Castilho L, et al. FY polymorphisms and vivax malaria in inhabitants of Amazonas State. Brazil Parasitol Res. 2010;106:1049\u201353.","journal-title":"Brazil Parasitol Res"},{"key":"4165_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12936-019-2918-4","volume":"18","author":"RK Abou-Ali","year":"2019","unstructured":"Abou-Ali RK, Dhyani A, Ter\u00e7o AL, Toro DM, Gomes KS, Tezza LC, et al. Impact of Duffy polymorphisms on parasite density in Brazilian Amazonian patients infected by Plasmodium vivax. Malar J. 2019;18:289.","journal-title":"Malar J"},{"key":"4165_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","volume":"42","author":"ET Nkhoma","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267\u201378.","journal-title":"Blood Cells Mol Dis"},{"key":"4165_CR20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/hdy.2011.90","volume":"108","author":"L Luzzatto","year":"2012","unstructured":"Luzzatto L. G6PD deficiency and malaria selection. Heredity. 2012;108:456.","journal-title":"Heredity"},{"key":"4165_CR21","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1182\/blood.V74.7.2550.bloodjournal7472550","volume":"74","author":"E Beutler","year":"1989","unstructured":"Beutler E, Kuhl W, Vives-Corrons JL, Prchal JT. Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-. Blood. 1989;74:2550\u20135.","journal-title":"Blood"},{"key":"4165_CR22","first-page":"262","volume":"91","author":"C De Araujo","year":"2006","unstructured":"De Araujo C, Migot-Nabias F, Guitard J, Pelleau S, Vulliamy T, Ducrocq R. The role of the G6PD AEth376G\/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal. Haematologica. 2006;91:262\u20133.","journal-title":"Haematologica"},{"key":"4165_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4269\/ajtmh.13-0622","volume":"90","author":"G Sirugo","year":"2014","unstructured":"Sirugo G, Predazzi IM, Bartlett J, Tacconelli A, Walther M, Williams SM. G6PD A- deficiency and severe malaria in The Gambia: heterozygote advantage and possible homozygote disadvantage. Am J Trop Med Hyg. 2014;90:856\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"4165_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004960","volume":"11","author":"A Manjurano","year":"2015","unstructured":"Manjurano A, Sepulveda N, Nadjm B, Mtove G, Wangai H, Maxwell C, et al. African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania. PLoS Genet. 2015;11: e1004960.","journal-title":"PLoS Genet"},{"key":"4165_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF00211017","volume":"94","author":"K Nafa","year":"1994","unstructured":"Nafa K, Reghis A, Osmani N, Baghli L, A\u00eft-Abbes H, Benabadji M, et al. At least five polymorphic mutants account for the prevalence of glucose-6-phosphate dehydrogenase deficiency in Algeria. Hum Genet. 1994;94:513\u20137.","journal-title":"Hum Genet"},{"key":"4165_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9: e1001339.","journal-title":"PLoS Med"},{"key":"4165_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1475-2875-10-271","volume":"10","author":"A Driss","year":"2011","unstructured":"Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, Stiles JK. Genetic polymorphisms linked to susceptibility to malaria. Malar J. 2011;10:271.","journal-title":"Malar J"},{"key":"4165_CR28","doi-asserted-by":"crossref","unstructured":"Ramos J\u00fanior WM, Sardinha JF, Costa MR, Santana MS, Alecrim MG, Lacerda MV. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon. Braz J Infect Dis. 2010;14:410\u20132.","DOI":"10.1590\/S1413-86702010000400017"},{"key":"4165_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/hdy.2011.16","volume":"107","author":"PW Hedrick","year":"2011","unstructured":"Hedrick PW. Population genetics of malaria resistance in humans. Heredity (Edinb). 2011;107:283\u2013304.","journal-title":"Heredity (Edinb)"},{"key":"4165_CR30","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025585","volume":"7","author":"JH Adams","year":"2017","unstructured":"Adams JH, Mueller I. The biology of Plasmodium vivax. Cold Spring Harb Perspect Med. 2017;7: a025585.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4165_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/376246a0","volume":"376","author":"C Ruwende","year":"1995","unstructured":"Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376:246\u20139.","journal-title":"Nature"},{"key":"4165_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000283","volume":"7","author":"T Leslie","year":"2010","unstructured":"Leslie T, Brice\u00f1o M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, et al. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. PLoS Med. 2010;7: e1000283.","journal-title":"PLoS Med"},{"key":"4165_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.crvi.2004.07.010","volume":"327","author":"H Wajcman","year":"2004","unstructured":"Wajcman H, Galact\u00e9ros F. Le d\u00e9ficit en glucose-6 phosphate d\u00e9shydrog\u00e9nase: protection contre le paludisme et risque d\u2019accidents h\u00e9molytiques [Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents]. C R Biol. 2004;327:711\u201320.","journal-title":"C R Biol"},{"key":"4165_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"4165_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12918-018-0669-4","volume":"13","author":"SR Adapa","year":"2019","unstructured":"Adapa SR, Taylor RA, Wang C, Thomson-Luque R, Johnson LR, Jiang RHY. Plasmodium vivax readiness to transmit: implication for malaria eradication. BMC Syst Biol. 2019;13:5.","journal-title":"BMC Syst Biol"},{"key":"4165_CR36","doi-asserted-by":"crossref","unstructured":"WHO. Severe malaria. Trop Med Int Health. 2014;19;7\u2013131.","DOI":"10.1111\/tmi.12313_2"},{"key":"4165_CR37","unstructured":"Malaria \u2013 drug therapy. 2.Malaria \u2013 diagnosis. 3.Antimalarials \u2013 administration and dosage. 4. Drug Therapy, Combination. 5.Guideline. Third Edition: WHO, 2015."},{"key":"4165_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13071-018-2787-7","volume":"11","author":"ACG Almeida","year":"2018","unstructured":"Almeida ACG, Kuehn A, Castro AJM, Vitor-Silva S, Figueiredo EFG, Brasil LW, et al. High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon. Parasit Vectors. 2018;11:194.","journal-title":"Parasit Vectors"},{"key":"4165_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood.V85.3.615.bloodjournal853615","volume":"85","author":"A Chaudhuri","year":"1995","unstructured":"Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in non erythroid tissues in Duffy-negative individuals. Blood. 1995;85:615\u201321.","journal-title":"Blood"},{"key":"4165_CR40","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1084\/jem.181.4.1311","volume":"181","author":"SC Peiper","year":"1995","unstructured":"Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ, et al. The Duffy antigen\/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med. 1995;181:1311\u20137.","journal-title":"J Exp Med"},{"key":"4165_CR41","unstructured":"ISBT http:\/\/www.isbtweb.org\/fileadmin\/user_upload\/Working_parties\/WP_on_Red_Cell_Immunogenetics_and\/008_FY_Alleles_v4.1.pdf. Accessed 2021."},{"key":"4165_CR42","doi-asserted-by":"crossref","unstructured":"Moura Neto, JP, Dourado MV, Reis MG, Gon\u00e7alves MS. A novel c.197T -> A variant among Brazilian neonates with glucose-6-phosphate dehydrogenase deficiency. Genet Mol Biol. 2088;31:33\u201335.","DOI":"10.1590\/S1415-47572008000100006"},{"key":"4165_CR43","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1111\/ijlh.13574","volume":"43","author":"NS Ferreira","year":"2021","unstructured":"Ferreira NS, Anselmo FC, Albuquerque SRL, Sanguino ECB, Fraiji NA, Marinho GB, et al. G6PD deficiency in blood donors of Manaus, Amazon Region, northern Brazil. Int J Lab Hematol. 2021;43:e290\u20133.","journal-title":"Int J Lab Hematol"},{"key":"4165_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1590\/1678-4685-gmb-2017-0253","volume":"41","author":"HS Oliveira","year":"2018","unstructured":"Oliveira HS, Silva A, Andrade GB, Gaia KC, Costa GL, Santos A, Guerreiro JF. Molecular genotyping of G6PD mutations and Duffy blood group in Afro-descendant communities from Brazilian Amazon. Genet Mol Biol. 2018;41:758\u201365.","journal-title":"Genet Mol Biol"},{"key":"4165_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/inthealth\/ihy060","volume":"11","author":"GJ Domingo","year":"2019","unstructured":"Domingo GJ, Advani N, Satyagraha AW, Sibley CH, Rowley E, Kalnoky M, et al. Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities. Int Health. 2019;11:7\u201314.","journal-title":"Int Health"},{"key":"4165_CR46","unstructured":"WHO. Gender, Health and Malaria. Geneva, World Health Organization, 2007."},{"key":"4165_CR47","doi-asserted-by":"publisher","first-page":"20113","DOI":"10.1073\/pnas.1109621108","volume":"108","author":"CL King","year":"2011","unstructured":"King CL, Adams JH, Xianli J, Grimberg BT, McHenry AM, Greenberg LJ, et al. Fy(a)\/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria. Proc Natl Acad Sci USA. 2011;108:20113\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"99","key":"4165_CR48","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1182\/blood.V99.4.1498","volume":"15","author":"A Hirono","year":"2002","unstructured":"Hirono A, Kawate K, Honda A, Fujii H, Miwa S. A single mutation 202G>A in the human glucose-6-phosphate dehydrogenase gene (G6PD) can cause acute hemolysis by itself. Blood. 2002;15(99):1498.","journal-title":"Blood"},{"key":"4165_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004031","volume":"3","author":"CI Fanello","year":"2008","unstructured":"Fanello CI, Karema C, Avellino P, Bancone G, Uwimana A, Lee SJ, et al. High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency. PLoS ONE. 2008;3: e4031.","journal-title":"PLoS ONE"},{"key":"4165_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006682","volume":"4","author":"Z Premji","year":"2009","unstructured":"Premji Z, Umeh RE, Owusu-Agyei S, Esamai F, Ezedinachi EU, Oguche S, et al. Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. PLoS ONE. 2009;4: e6682.","journal-title":"PLoS ONE"},{"key":"4165_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.parepi.2021.e00203","volume":"13","author":"C Tovar-Acero","year":"2021","unstructured":"Tovar-Acero C, Velasco MC, Avil\u00e9s-Vergara PA, Ricardo-Caldera DM, Alvis EM, Ramirez-Montoya J, et al. Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region. Parasite Epidemiol Control. 2021;13: e00203.","journal-title":"Parasite Epidemiol Control"},{"key":"4165_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12916-015-0302-y","volume":"13","author":"AM Siqueira","year":"2015","unstructured":"Siqueira AM, Lacerda MV, Magalh\u00e3es BM, Mour\u00e3o MP, Melo GC, Alexandre MA, et al. Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India. BMC Med. 2015;13:57.","journal-title":"BMC Med"},{"key":"4165_CR53","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.trstmh.2007.04.011","volume":"101","author":"CE Cavasini","year":"2007","unstructured":"Cavasini CE, Mattos LC, Couto AA, Bonini-Domingos CR, Valencia SH, Neiras WC, et al. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans R Soc Trop Med Hyg. 2007;101:1042\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4165_CR54","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ncomms1265","volume":"2","author":"RE Howes","year":"2011","unstructured":"Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, et al. The global distribution of the Duffy blood group. Nat Commun. 2011;2:266.","journal-title":"Nat Commun"},{"key":"4165_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S1516-84842000000100004","volume":"22","author":"MC Novaretti","year":"2000","unstructured":"Novaretti MC, Dorlhiac-Llacer PE, Chamone DA. Estudo de grupos sangu\u00edneos em doadores de sangue caucas\u00f3ides e negr\u00f3ides na cidade de S\u00e3o Paulo. Rev Bras Hematol Hemoter. 2000;22:1.","journal-title":"Rev Bras Hematol Hemoter"},{"key":"4165_CR56","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1046\/j.1537-2995.2000.40080949.x","volume":"40","author":"IJ Woolley","year":"2000","unstructured":"Woolley IJ, Hotmire KA, Sramkoski RM, Zimmerman PA, Kazura JW. Differential expression of the duffy antigen receptor for chemokines according to RBC age and FY genotype. Transfusion. 2000;40:949\u201353.","journal-title":"Transfusion"},{"key":"4165_CR57","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1365-2249.2009.03931.x","volume":"156","author":"IP Ceravolo","year":"2009","unstructured":"Ceravolo IP, Sanchez BA, Sousa TN, Guerra BM, Soares IS, Braga EM, et al. Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin Exp Immunol. 2009;156:502\u201310.","journal-title":"Clin Exp Immunol"},{"key":"4165_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jtbi.2012.08.024","volume":"316","author":"F Chamchod","year":"2013","unstructured":"Chamchod F, Beier JC. Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency. J Theor Biol. 2013;316:25\u201334.","journal-title":"J Theor Biol"},{"key":"4165_CR59","doi-asserted-by":"publisher","first-page":"13851","DOI":"10.1038\/s41598-018-32254-z","volume":"8","author":"FS Kano","year":"2018","unstructured":"Kano FS, de Souza AM, Torres LM, Costa MA, Souza-Silva FA, Sanchez BAM, et al. Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria. Sci Rep. 2018;8:13851.","journal-title":"Sci Rep"},{"key":"4165_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006987","volume":"13","author":"WQ He","year":"2019","unstructured":"He WQ, Shakri AR, Bhardwaj R, Fran\u00e7a CT, Stanisic DI, Healer J, et al. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical malaria. PLoS Negl Trop Dis. 2019;13: e0006987.","journal-title":"PLoS Negl Trop Dis"},{"key":"4165_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229574","volume":"15","author":"AJ DePina","year":"2020","unstructured":"DePina AJ, Pires CM, Andrade AJB, Dia AK, Moreira AL, Ferreira MCM, et al. The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination. PLoS ONE. 2020;15: e0229574.","journal-title":"PLoS ONE"},{"key":"4165_CR62","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4269\/ajtmh.2005.73.244","volume":"73","author":"TM Tran","year":"2005","unstructured":"Tran TM, Oliveira-Ferreira J, Moreno A, Santos F, Yazdani SS, Chitnis CE, et al. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. Am J Trop Med Hyg. 2005;73:244\u201355.","journal-title":"Am J Trop Med Hyg"},{"key":"4165_CR63","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2352-3026(15)00152-0","volume":"2","author":"S Uyoga","year":"2015","unstructured":"Uyoga S, Ndila CM, Macharia AW, Nyutu G, Shah S, Peshu N, et al. Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study. Lancet Haematol. 2015;2:e437\u201344.","journal-title":"Lancet Haematol"},{"key":"4165_CR64","doi-asserted-by":"publisher","first-page":"45963","DOI":"10.1038\/srep45963","volume":"7","author":"EC Mbanefo","year":"2017","unstructured":"Mbanefo EC, Ahmed AM, Titouna A, Elmaraezy A, Trang NT, Phuoc Long N, et al. Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis. Sci Rep. 2017;7:45963.","journal-title":"Sci Rep"},{"key":"4165_CR65","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood.2019000944","volume":"136","author":"L Luzzatto","year":"2020","unstructured":"Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. 2020;136:1225\u201340.","journal-title":"Blood"},{"key":"4165_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","volume":"81","author":"RE Howes","year":"2013","unstructured":"Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013;81:133\u2013201.","journal-title":"Adv Parasitol"},{"key":"4165_CR67","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/11536520-000000000-00000","volume":"33","author":"I Youngster","year":"2010","unstructured":"Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, et al. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf. 2010;33:713\u201326.","journal-title":"Drug Saf"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04165-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04165-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T06:03:19Z","timestamp":1651989799000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04165-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,8]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4165"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04165-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,8]]},"assertion":[{"value":"31 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was initiated after approval by the Research Ethics Committee (CEP) at FMT-HVD. To ensure patient welfare, all the patients included in the study signed the informed consent form (ICF), in compliance with CNS Resolutions 196\/96.The samples were from a larger study entitled \u201cClinical characterization of malaria complicated by <i>Plasmodium vivax<\/i>\u201d, approved by the National Commission for Ethics in Research (CONEP), in June 2009, opinion No. 343\/2009, protocol No. 25.000.011.792\/2009\u201315. This new project was approved by the Research Ethics Committee at FMT-HVD (study number 343\/2009) entitled \u201cStudy of DUFFY polymorphisms in patients infected with <i>Plasmodium vivax<\/i>\u201d under approval No. CAAE-0004.0.112.000\u201311 on 12\/29\/2011.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}